AXL and melanoma: Axl and MerTK are closely related RTKs that have both been associated with drug resistance and immunological resistance in melanoma [236,237,238,239] Antibody-mediated inhibition of Axl appeared to restore patient susceptibility to BRAF inhibitors [240].